DEVELOPMENT AND EVALUATION OF TRANSDERMAL FILMS LOADED WITH PROPRANOLOL

[1]  C. Setty,et al.  Chemical Penetration Enhancers for Transdermal Drug Delivery Systems , 2009 .

[2]  N. Pappano,et al.  Effects of Dimethylformamide and L-Menthol Permeation Enhancers on Transdermal Delivery of Quercetin , 2007, Pharmaceutical development and technology.

[3]  M. S. Srinath,et al.  Optimization of bilayer floating tablet containing metoprolol tartrate as a model drug for gastric retention , 2006, AAPS PharmSciTech.

[4]  M. Aqil,et al.  Transdermal drug delivery of labetolol hydrochloride: system development, in vitro; ex vivo and in vivo characterization. , 2005, Current drug delivery.

[5]  M. Fujii,et al.  Comparison of skin permeation enhancement by 3-l-menthoxypropane-1,2-diol and l-menthol: the permeation of indomethacin and antipyrine through Yucatan micropig skin and changes in infrared spectra and X-ray diffraction patterns of stratum corneum. , 2003, International journal of pharmaceutics.

[6]  T M Morgan,et al.  Transdermal penetration enhancers: applications, limitations, and potential. , 1999, Journal of pharmaceutical sciences.

[7]  P. Augustijns,et al.  In vivo evaluation of xanthan gum as a potential excipient for oral controlled-release matrix tablet formulation , 1998 .

[8]  M. Tobyn,et al.  Prediction of physical properties of a novel polysaccharide controlled release system. I. , 1996 .

[9]  Yie W. Chien,et al.  Transdermal Therapeutic Systems , 1987 .

[10]  Izhar Ahmed Syed,et al.  FORMULATION AND CHARACTERIZATION OF MATRIX AND TRIPLE-LAYER MATRIX TABLETS FOR CONTROLLED DELIVERY OF METOPROLOL TARTRATE , 2011 .

[11]  J. Boateng,et al.  Development and mechanical characterization of solvent-cast polymeric films as potential drug delivery systems to mucosal surfaces , 2009, Drug development and industrial pharmacy.

[12]  A. Ahad,et al.  A VALIDATED HPLC METHOD FOR ESTIMATION OF METOPROLOL IN HUMAN PLASMA , 2007 .